Abstract
Estradiol-17β was administered to adult, female guinea pigs in which collagen had been labelled during rapid growth by the chronic administration of 14C-proline. In skin, treatment reduced collagen biosynthesis and increased collagen degradation for de-novo biosynthesis elsewhere. In the granuloma produced by γ-carrageenan, estradiol-17β produced no change in the total amount of newly-synthesized collagen, in the amount of 14C-label derived from the degradation of prelabelled collagen or in the amount derived by the re-utilization of acid-soluble collagen. In the uterus and metaphyseal bone, estradiol-17β increased both collagenous and non-collagenous de-novo protein biosynthesis. The proline for this was derived, at least in part, from the degradation of prelabelled collagen, probably from skin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochemical and Biophysical Research Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
